Skip to content

R&D at other companies

TRA
First Tracks Biotherapeutics, Inc. Ordinary SharesTRAX
$33.96M-18.1%
Kulicke & Soffa Industries logo
Kulicke & Soffa IndustriesKLIC
$38.4M+3.2%
Axalta Coating Systems logo
Axalta Coating SystemsAXTA
$18M+5.9%
Materion logo
MaterionMTRN
$6.16M-5.3%
Hexcel logo
HexcelHXL
$17.8M+29.0%
Axcelis Technologies logo
Axcelis TechnologiesACLS
$28.52M+5.1%

Other financials

Income statement

See full
Revenue$67.8K-86.4%
Gross profit$3.7K-97.9%
Operating income-$4.5M+51.4%
Net income-$16.6M-77.7%
EPS (diluted)-$0.20+41.2%

Balance sheet

See full
Cash & equivalents$5.8M+671%
Total debt$970.5K
Total equity$3.3M+163%
Total assets$11.5M

Cash flow

See full
Operating cash flow-$7.5M-455%
CapEx$70.1K
Free cash flow-$7.6M

Valuation

See full
Market cap$97.82M
Enterprise value$92.99M
P/S226.3×

Profitability

See full
Gross margin24.9%
Operating margin-8,029.7%
Net margin-16,114.2%

Returns & leverage

See full
Return on equity7,086.2%
Debt / equity0.3×
Current ratio1.2×

Where this comes from

Reported directly by VenHub Global, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: VenHub Global, Inc. ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about VenHub Global, Inc. 's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is VenHub Global, Inc. 's R&D?
VenHub Global, Inc. (VHUB) reported R&D of $88.72K in Q1 2026.
How has VenHub Global, Inc. 's R&D changed year-over-year?
VenHub Global, Inc. 's R&D decreased by 70.6% year-over-year, from $301.36K to $88.72K.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.